EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial

Daniel Ginard, Manuel Barreiro-de Acosta, Pilar Nos, Irene Moraleja, Fernando Muñoz Nuñez, Xavier Aldeguer, Ana Echarri, Albert Villoria, Sabino Riestra, Marta Maia Boscá Watts, Yago González-Lama, Vanesa Royo und 6 weitere

Digestive Diseases · 2024

DOI: 10.1159/000540792 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Digestive Diseases, 2024. Verfasst von Daniel Ginard und 17 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain. Hauptthemen laut MEDLINE: Beclomethasone, Colitis, Ulcerative, Feces, Leukocyte L1 Antigen Complex. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Identifying novel treatment strategies for patients with ulcerative colitis (UC) and at risk of relapse is critical. The objective of this study was to assess the efficacy of beclomethasone dipropionate (BDP) in lowering fecal calprotectin (FC) levels in UC patients in clinical remission and at risk of relapse.

Methods

This multicenter study comprised a double-blind, randomized, placebo-controlled phase (part I) and an open-label, non-randomized phase (part II). Eligible participants with UC in clinical remission treated with 5-aminosalicylic acid and with FC levels ≥250 μg/g were randomized to receive 5 mg/day of BDP or placebo for 4 weeks (part I). At week 5, patients with FC ≥100 μg/g were treated with 5 mg/day of BDP for 4 weeks (part II), and FC levels were tested at week 9.

Results

Forty-three patients were randomized: 22 received BDP (group A) and 21 placebo (group B). At week 4, 13 patients (59.1%) in group A and 3 (17.6%) in group B had FC levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BeclomethasoneColitis, UlcerativeFecesLeukocyte L1 Antigen ComplexAdultFemaleHumansMaleMiddle AgedYoung AdultAnti-Inflammatory AgentsDouble-Blind MethodRecurrenceRemission InductionTreatment Outcome

Stichwörter der Autor:innen

Beclomethasone dipropionateFecal calprotectinRemissionUlcerative colitis

Substanzen

Anti-Inflammatory AgentsBeclomethasoneLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Gastroenterology Unit, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain.
  • Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
  • Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Hospital Galdakao-Usansolo, Galdakao, Spain.
  • Hospital Universitario de Salamanca, Salamanca, Spain.
  • Hospital Universitario Doctor Josep Trueta de Girona, Girona, Spain.

Zitieren

APA

Ginard, D., Barreiro-de Acosta, M., Nos, P., Moraleja, I., Muñoz Nuñez, F., Aldeguer, X., Echarri, A., Villoria, A., Riestra, S., Boscá Watts, M. M., González-Lama, Y., Royo, V., Ferreiro-Iglesias, R., Iborra, M., Elorza, A., Fernandez-Pordomingo, A., Sans, M., & Becalcu study (2024). Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial. Digestive Diseases. https://doi.org/10.1159/000540792

Vancouver

Ginard D, Barreiro-de Acosta M, Nos P, Moraleja I, Muñoz Nuñez F, Aldeguer X, et al. Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial. Digestive Diseases. 2024. doi:10.1159/000540792

BibTeX
@article{Ginard2024,
  author = {Ginard, Daniel and Barreiro-de Acosta, Manuel and Nos, Pilar and Moraleja, Irene and Muñoz Nuñez, Fernando and Aldeguer, Xavier and Echarri, Ana and Villoria, Albert and Riestra, Sabino and Boscá Watts, Marta Maia and González-Lama, Yago and Royo, Vanesa and Ferreiro-Iglesias, Rocío and Iborra, Marisa and Elorza, Ainara and Fernandez-Pordomingo, Alejandra and Sans, Miquel and Becalcu study, Becalcu study},
  title = {Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial},
  journal = {Digestive Diseases},
  year = {2024},
  doi = {10.1159/000540792}
}
Kostenlos starten →